arrow_back Back to App

LymeX Act: Boosting Innovation in Lyme Disease Fight

This act aims to accelerate research into Lyme disease, potentially leading to better prevention, diagnosis, and treatment methods. Citizens may benefit from faster and more effective medical help for Lyme disease in the future, improving their health and quality of life.
Key points
Authorizes $5 million for prize competitions to foster innovation in Lyme disease prevention, diagnosis, and treatment.
Aims to engage stakeholders like academia, nonprofits, and industry to facilitate patient-centered innovations.
Supports the development of rapid, patient-focused diagnostics and public awareness initiatives.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3637
Sponsor: Rep. Smith, Christopher H. [R-NJ-4]
Process start date: 2021-05-28
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

LymeX Authorization Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3637.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-28.

What are the main provisions?

Key points include:

  • Authorizes $5 million for prize competitions to foster innovation in Lyme disease prevention, diagnosis, and treatment.
  • Aims to engage stakeholders like academia, nonprofits, and industry to facilitate patient-centered innovations.
  • Supports the development of rapid, patient-focused diagnostics and public awareness initiatives.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Smith, Christopher H. [R-NJ-4].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health